← Back
Data updated: Mar 29, 2026
GD SEARLE LLC
Immunology
Big Pharma
GD SEARLE LLC is a major pharmaceutical company focused on Immunology.
1940
Since
28
Drugs
-
Trials
34
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
POTASSIUM CHLORIDE 2025-12-22
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
POTASSIUM CHLORIDE 2025-09-10
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (25)
POTASSIUM CHLORIDE LIDOCAINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM METARAMINOL BITARTRATE CALAN BEXTRA PROCAINE HYDROCHLORIDE DEMULEN 1/50-21 DEMULEN 1/35-21 DEMULEN 1/35-28 DEMULEN 1/50-28 AMINOPHYLLIN DIULO PRO-BANTHINE ENOVID ENOVID-E ENOVID-E 21 OVULEN-28 OVULEN-21 OVULEN NORINYL 1+80 21-DAY NORINYL 1+80 28-DAY AMMONIUM CHLORIDE CU-7 TATUM-T
Company Info
- First Approval
- 1940-04-19
- Latest
- 2022-04-29
- Applications
- 30
FDA Sponsor Names
GD SEARLE LLCGD SEARLE